A Registry Study of the AeriSeal® System or Lung Volume Reduction in Patients With Advanced Emphysema

Aeris Therapeutics

Status: Terminated

Conditions: Chronic Pulmonary Obstructive Disease; Emphysema

Study type: Observational

Funder types: Industry

Identifiers

NCT01449175

03-C11-001PLV

Details and patient eligibility

About

The purpose of this study is to provide post market clinical follow-up (PMCF) to obtain long term safety and efficacy information about the AeriSeal System treatment in patients with advanced emphysema.

Full description

The purpose of this study is to provide post market clinical follow-up (PMCF) to obtain long term safety and efficacy information about the AeriSeal System treatment in patients with advanced homogeneous or heterogeneous emphysema.

Enrollment: 54 estimated patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Confirmation of completion of Aeris' post market follow-up Continuation Study, 03-C10-001PLV.